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gical technique, postoperative care, immunosuppres-
sion, and lung preservation. However, even in technical-
ly uncomplicated transplantations, the function of the
transplanted lung may be transiently and sometimes crit-
ically deranged in the early postoperative period as a
result of multiple causes; in fact, injury to the donor lung
may occur before the death of the donor or during
ischemia, implantation, and reperfusion.1 A number of
different techniques for lung preservation have been pro-
posed in experimental and clinical lung transplantation.2
They have all been successful, but none is ideal.
Antegrade pulmonary artery flushing with modified
Euro-Collins solution or University of Wisconsin solu-
tion, mild hyperinflation, and cold storage is currently
the most widely used method. However, it presents a
number of drawbacks: Pulmonary arterial vasoconstric-
L ung transplantation is actually considered an effec-tive treatment for many types of end-stage lung dis-
ease; improved results are related to amelioration of sur-
Objective: Retrograde pneumoplegia seems to improve early graft func-
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formed antegrade pulmonary artery flushing with alprostadil
(prostaglandin E1) and modified Euro-Collins solution at the time of
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monary veins was performed at the back table, before reimplantation.
Hemodynamic variables, mean airway pressure, and blood gas analysis
were monitored at different time points. Postoperative volumetric mon-
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plantation response was assessed by a radiographic score; extubation
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were observed; 2 lungs harvested from a donor with multiple bone frac-
tures had fat emboli in the retrograde perfusate. Hemodynamic moni-
toring did not demonstrate any difference between the 2 groups. The
ratio of arterial oxygen tension to inspired oxygen fraction, extravascu-
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CARDIOTHORACIC TRANSPLANTATION
PREIMPLANTATION RETROGRADE PNEUMOPLEGIA IN CLINICAL LUNG TRANSPLANTATION
tion occurs3,4 and necessitates pretreatment of the donor
with bolus injection of prostaglandins5; the bronchial
circulation is not reached by the perfusate; clots and fat
or brain tissue emboli,6-8 especially in donors with
major trauma and multiple bone fractures, may jeopar-
dize the uniformity of the flushing and impair graft
reperfusion. Retrograde pneumoplegia through the pul-
monary veins can flush both the pulmonary and
bronchial circulations and may help to eliminate the
residual blood and macroscopic clots or other emboli
obstructing the pulmonary vessels. This technique has
been used in experimental and clinical lung transplanta-
tion and seems to offer better lung preservation with less
edema and improved oxygenation.9-11
We evaluated the role of retrograde pulmonary artery
flushing in addition to antegrade pneumoplegia in clin-
ical lung transplantation.
Patients and methods
During a 10-month period, 14 consecutive patients under-
going lung transplantation were enrolled in our study and ran-
domized into 2 groups. There were 6 sequential double lung
transplants (DLT) and 1 single lung transplant (SLT) in each
group; in group I we operated on 6 patients with cystic fibro-
sis and 1 with emphysema. In group II 6 patients had cystic
fibrosis and 1 had idiopathic pulmonary fibrosis. The mean
age of patients was 35.8 ± 10.6 years in group I and 32.8 ± 10
years in group II. In group I we performed antegrade pul-
monary artery flushing with a bolus injection of alprostadil
(prostaglandin E1; 500 ng) and modified Euro-Collins solu-
tion (60 mL/kg) at the time of retrieval only; to keep a rela-
tively high alprostadil concentration in the donor lungs, anoth-
er 500 ng was mixed with the flush solution. In group II
additional retrograde flushing via the pulmonary veins with
modified Euro-Collins solution (30-40 mL/kg) was performed
in the recipient operating room, before implantation, with the
lungs still inflated. No alprostadil was added to the retrograde
flush. After retrograde pneumoplegia, in case of SLT the
donor lung was immediately reimplanted; in case of DLT the
first lung was implanted immediately and the second one was
stored in the ice chest and retrieved only after completion of
the anastomoses of the first lung. The quantitative data of all
the donors (blood gas analysis, duration of stay in the inten-
sive care unit [ICU], cause of death, chest radiograph, smok-
ing habit, number of episodes of hypotension, and dopamine
dose) and ischemic times were recorded. The surgical tech-
nique for in situ separate extraction of the heart and the dou-
ble lung block was standard. No recipient required the use of
cardiopulmonary bypass during the operation. Postoperative
care was the same for all patients: fluid restriction with high
doses of diuretics, inotropic support, antibiotics, and the
immunosuppressive regimen were always ordered by the
same team. Standard hemodynamic monitoring (cardiac
index, central venous pressure, mean pulmonary artery pres-
sure, mean arterial pressure, pulmonary capillary wedge pres-
sure, pulmonary vascular resistance indexed, systemic vascu-
lar resistance indexed, intrapulmonary shunt fraction),
indexed alveolar-arterial oxygen (A-aDO2/PO2) gradient,
blood gas analysis, and mean airway pressure were monitored
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Table I. Donor population data
Group I Group II 
Age (y) 27.2 ± 10.2 27.4 ± 8.4
Smoking 3/7 (42%) 4/7 (57%)
Hypotension* 2 2
Dopamine dose (m g/kg/min) 7 ± 4 8 ± 4
PaO2 (mm Hg)† 502 ± 25 440 ± 32
ICU stay (h) 2.2 ± 0.57 2.7 ± 1.1
Pao2, Arterial oxygen tension; ICU, intensive care unit.
*Number of episodes of systemic hypotension (<80 mm Hg) requiring resus-
citation before donation. 
†Inspired oxygen fraction = 1.
Fig 1. A, Chest x-ray film on day 2 of a patient in group I
receiving DLT for cystic fibrosis. The reimplantation
response is visible in both lungs with a prevalence on the left
side, which was transplanted first. B, Chest x-ray film on day
2 of a patient in group II receiving DLT for cystic fibrosis.
Virtually no reimplantation response is shown in either lung.
A
B
after transplantation, after arrival in the ICU (time 0), and after
6, 12, 24, 36, and 48 hours. Postoperative volumetric moni-
toring (thermal green dye indicator dilution COLD system)
(PULSION Medical Systems; Munich, Germany) was per-
formed to assess extravascular lung water. The degree of reim-
plantation response at chest radiography was evaluated by
means of the scoring system proposed by the St Louis
group12; each of 4 lung regions on chest radiographs (perihi-
lar, apical, lateral, and basilar) was assigned a numeric value
(0 = normal lung; 1 = minimal interstitial infiltrate that does
not obscure lung vessels; 2 = moderate interstitial infiltrate
that partly obscures the lung vessels with or without air bron-
chograms; 3 = extensive alveolar infiltrate that completely
obscures the lung vessels with or without air bronchogram).
The total lung score for each lung (from 0 to 12) was the sum
of the 4 regions and was recorded for each of the first 3 post-
operative days. Extubation time and ICU stay were also
recorded. At the end of the operation, before the chest was
closed, samples of the transplanted lungs were taken with a
GIA stapler (Ethicon, Inc, Somerville, NJ) and bovine peri-
cardial strips (Peri-Strip surgical tape; Bio-Vascular, Inc, St
Paul, Minn) to buttress the suture line.
Data were collected and managed with the aid of a com-
mercial spreadsheet software package (Microsoft Excel 97,
version 6.0, Redmond, Wash). All data were expressed as
mean ± standard deviation of the mean. The data of the 2
groups were compared with the analysis of variance for
repeated measures. Statistical analysis was performed with
the GLM procedure of the SAS package (version 6; SAS
Institute Inc, Cary, NC).
Results
All patients underwent successful transplantation and
were discharged from the hospital. In group I, 4 donors
came from car accidents, 1 had committed suicide, and
2 had brain hemorrhage; in group II, 3 donors came
from car accidents and 4 had brain hemorrhage. One
donor in each group was marginal (PaO2 < 350 mm Hg
and unilateral lung contusion). The data of the donor
population in each group are reported in Table I. The
ischemia time for SLT and the first lung of DLT was
271 ± 40 minutes and 253 ± 34 minutes for groups I
and II, respectively; for the second lung it was 383 ± 40
minutes and 383 ± 32 minutes, respectively. During ret-
rograde flushing, blood and clots came out from the
main pulmonary artery in all lung blocks; 2 lungs har-
vested from a donor with multiple bone fractures had
macroscopic fat emboli in the retrograde perfusate.
Most of the posterior segments of the lower lobes were
less perfused after antegrade flushing; retrograde flush-
ing improved whitening of the donor lungs by washing
out the residual blood. The postoperative cumulative
chest x-ray score was significantly better in group II
(mean scores for group I and group II: 7.2 ± 1.2 and 2.3
± 0.72, respectively; P = .03) (Fig 1). The mean intu-
bation time was 51 ± 31 hours for group I and 31.7 ±
10.7 hours for group II; the mean stay in the ICU was
6.5 ± 2.5 days and 5.2 ± 2.3 days, respectively.
Standard hemodynamic monitoring (mean pulmonary
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Table II. Standard hemodynamic monitoring after lung transplantation in group I and II
0 6 1 12 18 36 48 P value
Mean arterial pressure (mm Hg)
Group I 89 ± 11 82 ± 13 86 ± 13 88 ± 6 88 ± 10 96 ± 10 99 ± 9 .2
Group II 90 ± 14 83 ± 13 85 ± 13 98 ± 7 97 ± 14 98 ± 7 112 ± 12
Cardiac index (L · min · m2)
Group I 4.2 ± 1.4 4.4 ± 1.2 4.7 ± 1 4.9 ± 1 5 ± 1 5.3 ± 1.3 5.4 ± 0.7 .4
Group II 4.6 ± 1 4.9 ± 0.5 5.3 ± 1.2 5.1 ± 1 5.2 ± 1.4 5.5 ± 1 5.2 ± 1
Central venous pressure (mm Hg)
Group I 11 ± 7 10 ± 4 11 ± 4 11 ± 3 12 ± 4 10 ± 4 9 ± 4 .3
Group II 7 ± 4 9 ± 2 9 ± 3 10 ± 3 9 ± 3 11 ± 3 10 ± 3
Systemic vascular resistance indexed (dynes · sec · cm–5 · m–2)
Group I 1655 ± 467 1406 ± 702 1305 ± 379 1196 ± 397 1413 ± 376 1415 ± 691 1251 ± 547 .5
Group II 1674 ± 479 1336 ± 346 1430 ± 544 1488 ± 437 1499 ± 397 1480 ± 364 1624 ± 493
Mean pulmonary artery pressure (mm Hg)
Group I 23 ± 5 25 ± 6 26 ± 6 28 ± 7 26 ± 6 25 ± 6 24 ± 4 .5
Group II 24 ± 4 25 ± 3 26 ± 4 23 ± 6 28 ± 6 29 ± 6 28 ± 7
Pulmonary capillary wedge pressure (mm Hg)
Group I 14 ± 5 15 ± 5 17 ± 5 16 ± 4 17 ± 5 14 ± 2 14 ± 4 .2
Group II 12 ± 3 13 ± 1 15 ± 6 12 ± 5 14 ± 5 15 ± 3 15 ± 6
Pulmonary vascular resistance indexed (dynes · sec · cm–5 · m–2)
Group I 193 ± 114 174 ± 139 161 ± 78 216 ± 123 182 ± 98 191 ± 55 112 ± 60 .2
Group II 268 ± 106 229 ± 76 191 ± 78 173 ± 39 238 ± 113 143 ± 89 212 ± 105
The variables were measured at arrival in the intensive care unit (time 0) and after 6, 12, 18, 24, 36, and 48 hours. P values refer to the “between-groups” analyses.
artery pressure, mean arterial pressure, central venous
pressure, cardiac index, pulmonary artery wedge pres-
sure, systemic vascular resistance indexed, and pul-
monary vascular resistance indexed) failed to demon-
strate any significant difference between the 2 groups
(Table II). The ratio of arterial PO2 to inspired oxygen
fraction (Fig 2) was improved in group II at each time
point, as well as extravascular lung water index (Fig 3),
but the difference did not reach statistical significance,
probably because of the small sample size and high
standard deviation. However, extravascular lung water
index was significantly increased in group I during the
operation, immediately after completion of implanta-
tion (17 ± 2.6 vs 11.8 mL/kg ± 2.8 mL/kg; P = .008). A
statistically significant improvement was present in
group II in terms of indexed alveolar-arterial oxygen
gradient (Fig 4), intrapulmonary shunt fraction (Fig 5),
mean airway pressure (Fig 6), and chest x-ray score.
Histologic examination showed a mild reduction of
alveolar edema in group II patients (Fig 7).
Discussion
Early graft dysfunction is an ill-defined clinical enti-
ty resulting from a multifactorial lung injury starting
within the donor and continuing during organ harvest-
ing, storage, implantation, and reperfusion. Two clini-
cal forms of nonimmunologically mediated damage
are the so-called reimplantation response and primary
graft failure.13 The first is manifested by patchy infil-
trates resembling pulmonary edema, beginning on the
first day and reaching a peak by day 3; it is usually
associated with a mildly elevated alveolar-arterial oxy-
gen gradient and a decrease in pulmonary compliance,
but it appears to have minimal clinical impact. On the
contrary, primary graft failure is associated with a sig-
nificant morbidity and mortality, a marked decline in
pulmonary function, and histologic features of diffuse
alveolar damage. Early graft dysfunction may be relat-
ed to several donor-acquired problems, such as pul-
monary embolism (clots, fat, brain tissue), lung contu-
sion, or inhalation; also the resuscitation maneuvers
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Fig 2. The ratio of arterial oxygen tension to inspired oxygen
fraction (Pao2/Fio2) in groups I and II.
Fig 3. Extravascular lung water indexed (EVLWI) (mL/kg) in
groups I and II.
Fig 4. Alveolar-arterial oxygen gradient indexed to PO2 (A-aDO2/Po2) in groups I and II.
(eg, massive blood transfusions, infusion of fluids)
may contribute to the impairment of postoperative
lung function.6 Our early experience with clinical lung
transplantation forced us to face primary graft failure
in 2 cases: autopsy showed multiple pulmonary
embolism in 1 patient and fat embolism in the second
patient. For this reason retrograde pneumoplegia was
evaluated as a possible means to improve viability of
the pulmonary circulation by reducing the risk of
embolism, improving oxygenation, and preventing
early dysfunction, especially when marginal donors or
lungs from patients with multiple fractures are to be
used. Experimental and clinical reports have shown
that retrograde pulmonary flushing is not detrimental,
can improve early lung function after transplantation,
and reduces the radiologic appearance of the reimplan-
tation response.9-11
The pulmonary venous circulation is a low resis-
tance–high capacity network; pneumoplegic solution
administered through this route is straightforward and
results in a rapid and uniform distribution of the solu-
tion.14 Experimental studies have demonstrated that
retrograde pneumoplegia can reach vascular segments
that are not flushed by the forward route.15 Also, less
well ventilated areas, such as the posterior segments of
the lower lobes, are better flushed.14,16 Small clots can
be removed by the back flow, and even if they remain
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Fig 5. Intrapulmonary shunt fraction (Qs/Qt) in patients in groups I and II.
Fig 6. Mean airway pressure (mAwP) in group I and group II
patients.
A
B
Fig 7. Histologic studies of samples of lung parenchyma
(hematoxylin and eosin stain; original magnification · 40)
taken in group I (A) and group II (B) before closure of the
chest. A mild reduction in edema is evident in group II.
in place the distal vascular bed can be reached by the
retrograde perfusate.
Retrograde pneumoplegia also has the advantage of
flushing the bronchial circulation through the bron-
chopulmonary anastomoses, enhancing airway protec-
tion17; experimental lung transplantation has shown
that retrograde flushing improves flow of the perfusate
to the trachea and bronchi, whereas antegrade delivery
improves flow to the lung parenchyma.14
Many indices have been used to test lung function
after transplantation; gas exchange is generally consid-
ered a reliable indicator,18 because early damage may
impair the lung exchange capacity without any morpho-
logic alteration.19 We have shown a significant decrease
of the intrapulmonary shunt fraction, alveolar-arterial
oxygen gradient, mean airway pressure, and reimplanta-
tion response. The extubation time, ICU stay, ratio of
arterial oxygen to inspired oxygen fraction, and extra-
vascular lung water index improved in group II, even if
the difference was not statistically significant. However,
a few points deserve further comments: we expected
that the improvement in chest x-ray score, indexed alve-
olar-arterial PO2 gradient, intrapulmonary shunt frac-
tion, and mean airway pressure would be paralleled by
a significant decrease of pulmonary artery pressure, pul-
monary vascular resistance, and extravascular lung
water. The improved viability of the pulmonary circula-
tion achieved with the retrograde flush should have
resulted in a lower pulmonary artery pressure and pul-
monary vascular resistance; however, the vasodilating
drugs (nitric oxide, alprostadil) routinely administered
immediately after reperfusion probably helped to elimi-
nate any possible difference between the 2 groups. Also,
the differences in terms of extravascular lung water,
which were evident during the operation, were already
reduced to nonsignificant levels after a few hours; how-
ever, the histologic studies of lung biopsy specimens
taken before closing the chest confirmed a mild differ-
ence in alveolar edema between the 2 groups. These
clinical findings confirm the experimental work pub-
lished by other authors20: in well-functioning lungs, the
edema related to preservation progressively resolves
during the first hours after reperfusion and no irre-
versible damage results. In DLT we may postulate that,
along with the increased viability of the pulmonary ves-
sels, retrograde flushing may have contributed to
improved preservation of the second lung, which has
prolonged ischemic time. This aspect of lung preserva-
tion should be further investigated by administering ret-
rograde pneumoplegia at the time of harvesting. For this
reason, we now administer retrograde pneumoplegia
immediately after antegrade flushing at the time of lung
extraction. An additional advantage of this technique is
that any possible emboli in the lung vasculature during
antegrade pneumoplegia6 can be immediately washed
out with the retrograde flushing.
Also, it is impossible to establish whether the differ-
ences between our 2 groups were simply related to the
fact that the lungs in group II were flushed twice (in
this case the possible role of a second antegrade flush
should be investigated) or to the higher volume of total
flushing solution delivered (5.5-6 L in group II vs 3.5-
4 L in group I).
The small number of patients enrolled in our study
does not allow us to draw definitive conclusions; how-
ever, along with the improvement in early lung func-
tion, substantiated by a better intrapulmonary shunt
fraction, decreased alveolar-arterial oxygen difference,
and reduced reperfusion edema at chest radiograph, we
have observed blood and clots in the retrograde per-
fusate of all lung blocks and macroscopic fat emboli in
the grafts harvested from donors with multiple bone
fractures. However, we cannot postulate what their
impact might have been without retrograde flushing.
Retrograde pneumoplegia is not detrimental and seems
to improve early graft function. However, the specific
role of this technique of preservation should be investi-
gated by further experimental and clinical investigation.
We thank Dr Maria Luce Vegna for statistical analysis, Dr
Edoardo Pescarmona for reviewing the histologic studies of
the transplanted lungs, and Maurizio Seminara and Mario
Passacantilli for preparing the illustrations.
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Discussion
Dr Stuart W. Jamieson (San Diego, Calif). First I would
like to congratulate you on a very fine paper and what I think
is probably a significant advance in pulmonary preservation
techniques and our understanding of pulmonary preservation.
You remember, of course, that the first lung transplants
were combined with the heart as heart-lung transplants, and
at Stanford in 1981 and 1982, since we were so unsure about
the safety of our preservation methods, the donor was
brought into the adjacent operating room to minimize the
ischemic time. You can imagine the difficulties this imposed,
especially with the transport of bodies across state and even
international borders. Clearly that was not going to be sup-
portable in the long term. We then determined that the so-
called modified Euro-Collins solution was a satisfactory solu-
tion to be used to flush the lungs and to get it cold without
inducing injury. That was used in our first clinical case in
November 1982. That patient, incidentally, is still alive, 161⁄2
years after the transplant, and is the longest surviving recipi-
ent of a lung transplant. When we used this solution in mon-
keys, we found that preservation of the lungs for 24 hours
was tolerated. Although I am sure other solutions might
equally well be used and perhaps be even better, it did not
seem fruitful to pursue endlessly various minor variations of
chemical composition. I believed then, and I still believe, that
the essential factor is to get the lungs cold and keep them so
until revascularization. In any event, our group has continued
to use the same solution for the past 16 years, and we have
now exceeded 8 hours of ischemia clinically without appar-
ent injury.
Your paper explores a different topic, a different route of
administration with the same solution. I think it is a useful
contribution. The major point is the ability to flush out par-
ticulate material and clot, which in the donors is probably
common. This will enhance preservation and also will
improve reperfusion after implantation.
I have a number of questions. First, we found in the labo-
ratory many years ago that the use of alprostadil was not
helpful, and was possibly harmful, and we abandoned this 15
years ago. Are you sure that it is necessary?
Dr Venuta. A number of papers have been published in the
international literature either in favor of or against the use of
alprostadil. We have used alprostadil since our first lung
transplant 7 years ago, and we have never had any problem.
We believe that alprostadil should be used not only because
its vasodilating activity compensates the action of the high
potassium concentration in the preservation solution, but also
because it has other features that can help to improve early
lung function and prevent primary graft failure. In fact, we do
not use alprostadil only at the time of harvesting; it is part of
our routine protocol and is infused for at least 48 hours after
the transplant. However, I am aware of the work that you pub-
lished several years ago. I think the role of alprostadil should
be further investigated, especially when retrograde pneumo-
plegia is used.
Dr Jamieson. I am always concerned about the term pneu-
moplegia, because, unlike in cardioplegia, the lung is not
strictly paralyzed. Did you give the retrograde solution
immediately after the antegrade flush solution in the donor
operating room? I thought you said that you retrogradely
flushed the solution when you brought the lungs to the recip-
ient operating room.
Dr Venuta. You understood correctly; retrograde flushing
was administered through the pulmonary veins (each vein sep-
arately) when the double lung block arrived at our institution.
Dr Jamieson. I would imagine that it would be most con-
structive to do it while the donor organs are being harvested,
particularly if you wanted to fully revascularize and cool var-
ious areas of the lung that had been blocked by particulate
debris. One other problem, of course, is that the 2 groups are
not strictly compatible because, in effect, you gave your sec-
ond group a second dose of flush solution, albeit backward.
Dr Venuta. I agree with you; it will certainly be more
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effective to give both antegrade and retrograde flushing in the
donor operating room, during harvesting, before taking the
lungs out, or at the back table.
Dr Jamieson. I very firmly believe that maintenance of a
low inspired oxygen fraction and maintenance of a high
hematocrit value are keys to success in the early management
of a lung transplant recipient. These are probably some of the
most important factors in the assessment of your chest x-ray
score. How carefully were you able to compensate for that in
both your groups?
Dr Venuta. Fluid restriction is one of the key factors for
success in lung transplantation. All patients of this study did
well, and we did not observe any primary graft failure or
other major problems. Fluid balance was carefully monitored;
extravascular lung water was assessed by the COLD system
during the operation and after the procedure, in the ICU. All
patients were kept extremely dry, allowing a satisfactory
hemodynamic performance. Extravascular lung water was
higher immediately after reimplantation in the group not
receiving retrograde flushing; however, 6 to 8 hours later, in
the ICU, extravascular lung water started to decrease, and the
differences between the 2 groups were kept at levels that were
not statistically significant.
Dr Jamieson. I would like to congratulate you on your
paper. You have made a useful contribution that I believe will
become a routine measure.
Dr Vaughn A. Starnes (Los Angeles, Calif). I have two
questions. First, a high proportion of your patients had cystic
fibrosis. Was cardiopulmonary bypass used in all or some of
them? How did you do the actual implant? Use or nonuse of
bypass would make a difference, and if the techniques dif-
fered, there needs to be a variable control for it.
Dr Venuta. We never had to use cardiopulmonary bypass.
At our institution bypass is not used electively. It is used
only when required to maintain hemodynamic stability and
oxygenation.
Dr Starnes. One of the issues that you discussed is that the
first lung receives all the cardiac output. In the case of reim-
plantation, that predisposes it to pulmonary edema. Did you
see that in either of your groups? I think the first chest x-ray
film that you showed was more indicative of an implantation
response.
Dr Venuta. There was a great difference in terms of reim-
plantation response on the chest x-ray film between group I
and II patients. There was, as usual, a more important reim-
plantation response in the lung transplanted first, probably
because it receives all the cardiac output during reimplanta-
tion of the second lung. Differences in terms of edema
between the 2 groups were confirmed histologically, with
biopsy specimens taken from the first reimplanted lung.
Dr Starnes. I have one other comment. Patients with cys-
tic fibrosis come to the operating room in differing condi-
tions. Some are in stable condition, and some have indulin
infections. It is not until you start mobilizing the lungs that
you observe the endotoxemic effect indicating whether ongo-
ing infection is present. Did you see that in any of your
patients? Did some of your patients have to have vasocon-
strictors to support their systemic blood pressure during the
operation, and was that controlled for?
Dr Venuta. Patients with cystic fibrosis may show different
clinical parameters at the time of transplantation. One of our
patients arrived already intubated and ventilated in the operat-
ing room. Our policy is to perform a careful toilette of the air-
way with the fiberoptic bronchoscope before starting the oper-
ation. We were able to aspirate 200 to 300 mL of dense
secretions from the bronchial tree. Most of our patients re-
quired extended inotropic support during transplantation to
avoid cardiopulmonary bypass. Transesophageal echocardiog-
raphy was extremely useful to evaluate the morphology and
contractility of the right and left sides of the heart during the
procedure.
Dr Starnes. In no way do I want to de-emphasize the
importance of the paper, because it makes a valuable point.
You have treated a very difficult group of patients in whom
there would be many factors to control for. It is probably dif-
ficult to control for all those in the cystic fibrosis population.
In our living donor series, when those lobes are flushed,
there are frequently regions that do not perfuse well. They
can be identified simply because they do not lose their color,
and continuing the perfusion does not change that. If you then
give retrograde pneumoplegia, most of those regions will be
perfused, which implies that there may be some advantage in
distribution of pneumoplegia with this technique. We have
continued to do that.
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